Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 69NIH 20INDUSTRY 17NETWORK 7OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Sarcoma, Kaposi 1Rectal Neoplasms 1Oesophagogastric Cancer 1Non-small Cell Lung Cancer Metastatic 1Metastatic Colorectal Cancer With Left-sided Primary Tumor 1Meningeal Carcinomatosis 1HER-2 Negative Breast Cancer 1EGFR Positive Non-small Cell Lung Cancer 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Liver Metastasis 1Advanced Primary Liver Cancer 1Adenocarcinoma of Lung 1

Interventions

Capecitabine 8Fluorouracil 6Radiotherapy 5Leucovorin 5Oxaliplatin 4Laparoscopy 4XELOX 3Cetuximab 3Irinotecan 2Folfox protocol 2Drug Therapy 2Chemoradiotherapy 2selinexor 1citric acid, ispaghula husk, sodium bicarbonate drug combination 1capecitabine-irinotecan combination 1Vitamin D Response Element 1Vi-siblin 1Transanal Endoscopic Microsurgery 1Robotics 1Robotic Surgical Procedures 1Psyllium 1Polyethylene Glycols 1N-hydroxy-4-acetylaminostilbene 1Metronidazole 1Mastectomy, Segmental 1Liver Extracts 1Immunohistochemistry 1Frozen Sections 1Fluorescein Angiography 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Rectal Neoplasms × Bevacizumab × Clear all
NCT05640726 2022-12-07

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Fujian Cancer Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡